Pharmaceuticals say proposal to extend Ozempic patent pressures health spending
Pharmaceutical companies in Brazil criticize a proposal to extend the patent duration of medications, arguing it could increase healthcare costs and reduce access.
The pharmaceutical spending case explodes, Schillaci writes to Aifa: 'Credibility compromised'
Minister of Health Orazio Schillaci expresses concerns over rising pharmaceutical spending in Italy and calls for action from Aifa.
The Dynamics and Barriers in the Pharmaceutical Sector
The Greek pharmaceutical industry has announced investments and a stable framework for pharmaceutical policy from 2026 to 2030, while multinational companies seek governmental support for innovation and increased funding for pharmaceutical spending.
Digital "block" on exceeding pharmaceutical spending - Georgiadis' announcements
Health Minister Adonis Georgiadis announced two significant interventions aimed at rationalizing pharmaceutical expenditures in early 2026 during a New Year event for the Association of Pharmaceutical Enterprises of Greece.